Annexon (ANNX) Projected to Post Earnings on Tuesday

Annexon (NASDAQ:ANNX) is expected to be issuing its quarterly earnings data before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($0.28) per share for the quarter.

Annexon (NASDAQ:ANNX) last announced its quarterly earnings data on Monday, March 3rd. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by ($0.05). On average, analysts expect Annexon to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Annexon Trading Down 3.6 %

Shares of ANNX stock opened at $2.40 on Monday. The firm has a market capitalization of $263.30 million, a P/E ratio of -2.29 and a beta of 1.14. Annexon has a 1 year low of $2.30 and a 1 year high of $8.40. The firm’s fifty day simple moving average is $3.25 and its 200 day simple moving average is $5.10.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ANNX. HC Wainwright reaffirmed a “buy” rating and set a $30.00 price objective on shares of Annexon in a research report on Tuesday, December 17th. Needham & Company LLC reaffirmed a “buy” rating and issued a $16.00 price target on shares of Annexon in a report on Tuesday, March 4th. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $15.80.

Annexon Company Profile

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.